Speaker illustration

Doctor Andreas Papazoglou

Naval Hospital of Athens, Athens (Greece)

Member of:

European Society of Cardiology

Concomitant coronary artery disease development in identical twins: a case report and a systematic literature review

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary artery disease in special situations

Thumbnail

Prognostic significance of thyroid disease in atrial fibrillation

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Remodelling, prognosis, and outcomes in atrial fibrillation

Thumbnail

Clinical impact of peri-device leaks following percutaneous left atrial appendage occlusion: a systematic review and meta-analysis

Event: ESC Congress 2022

Topic: Left Atrial Appendage (LAA) Closure

Session: Patent foramen ovale closure and left atrial appendage closure

Thumbnail

Prognostic impact of secondary prevention treatment following myocardial infarction with non-obstructive coronary arteries: Bayesian versus frequentist meta-analysis

Event: ESC Congress 2022

Topic: Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA)

Session: All about MINOCA and Tako-Tsubo

Thumbnail

Prognostic significance of diabetes mellitus in patients with atrial fibrillation

Event: EHRA 2021

Topic: Pathophysiology and Mechanisms, Other

Session: Pathophysiology of atrial fibrillation and beyond I

Thumbnail

Polypharmacy and major adverse events in atrial fibrillation

Event: EHRA 2021

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Optimal therapy of atrial fibrillation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb